These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6978333)

  • 21. [Detection of beta-lactamases in the Bacteroides fragilis group].
    Martin C; Dubreuil L; Sedallian A; Romond C
    Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The contribution of beta-lactamases to beta-lactam resistance in Bacteroides fragilis.
    Simpson IN; Page CD; Harper PB
    J Antimicrob Chemother; 1982 Jan; 9(1):29-45. PubMed ID: 6977524
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug resistance of bacteria--the current status and future prospect. 6. Bacteroides].
    Okada J
    Nihon Rinsho; 1984 Mar; 42(3):690-5. PubMed ID: 6471458
    [No Abstract]   [Full Text] [Related]  

  • 24. Cephalosporinases associated with outer membrane vesicles released by Bacteroides spp. protect gut pathogens and commensals against β-lactam antibiotics.
    Stentz R; Horn N; Cross K; Salt L; Brearley C; Livermore DM; Carding SR
    J Antimicrob Chemother; 2015 Mar; 70(3):701-9. PubMed ID: 25433011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis].
    Isono M; Kawashima K; Yamada N; Aoki M; Kobayashi T; Sawa K; Watanabe K; Ueno K
    Jpn J Antibiot; 1982 Jul; 35(7):1667-72. PubMed ID: 6757469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila.
    Shannon K; King A; Phillips I
    J Antimicrob Chemother; 1986 Jan; 17(1):45-50. PubMed ID: 3485091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Typing by isoelectric focusing of beta-lactamase enzymes in Klebsiella and Enterobacter strains resistant to the new beta-lactam antibiotics].
    Gür D; Akalin HE; Baykal M; Doğrul F
    Mikrobiyol Bul; 1992 Jan; 26(1):1-11. PubMed ID: 1574017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 42():72-82. PubMed ID: 6335601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro and in-vivo activities of a novel cephamycin MT-141 against the Bacteroides fragilis group in comparison with six cephem antibiotics.
    Kasai T; Hara T; Tamura A; Kazuno Y; Inouye S; Goto S; Kuwahara S
    J Antimicrob Chemother; 1985 Jun; 15(6):701-14. PubMed ID: 3928575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
    Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
    J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-19393 S2 and H2, new carbapenem antibiotics. IV. Inhibitory activity against beta-lactamases.
    Okonogi K; Nozaki Y; Imada A; Kuno M
    J Antibiot (Tokyo); 1981 Feb; 34(2):212-7. PubMed ID: 6975270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.
    Dornbusch K; Olsson-Lijequist B; Nord CE
    J Antimicrob Chemother; 1980 Mar; 6(2):207-16. PubMed ID: 6966626
    [No Abstract]   [Full Text] [Related]  

  • 34. Cefotetan activity against Gram-negative aerobes and anaerobes.
    Moosdeen F; Maskell J; Philpott-Howard J; Williams JD
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():59-65. PubMed ID: 6601657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Lactamases: A Focus on Current Challenges.
    Bonomo RA
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 37. Progress toward inhibitors of metallo-β-lactamases.
    McGeary RP; Tan DT; Schenk G
    Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.
    Snydman DR; Jacobus NV; McDermott LA; Goldstein EJ; Harrell L; Jenkins SG; Newton D; Patel R; Hecht DW
    Anaerobe; 2017 Feb; 43():21-26. PubMed ID: 27867083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sch 29482: comparative activity against Enterobacteriaceae multiply-resistant to beta-lactam antibiotics and mycobacteria.
    Sanders CC; Sanders WE
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():59-69. PubMed ID: 6977534
    [No Abstract]   [Full Text] [Related]  

  • 40. Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii.
    Hornstein M; Sautjeau-Rostoker C; Péduzzi J; Vessières A; Hong LT; Barthélémy M; Scavizzi M; Labia R
    FEMS Microbiol Lett; 1997 Aug; 153(2):333-9. PubMed ID: 9271860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.